Genital Dysbiosis and Different Systemic Immune Responses Based on the Trimester of Pregnancy in SARS-CoV-2 Infection
Authors:
- Giuseppina CampiscianoGCGiuseppina Campisciano
- Alice SorzASAlice Sorz
- Carolina CasonCCCarolina Cason
- Nunzia ZanottaNZNunzia Zanotta
- Fabrizia GionechettiFGFabrizia Gionechetti
- Maria PiazzaMPMaria Piazza
- Petra CarliPCPetra Carli
- Francesca Maria UlianaFUFrancesca Maria Uliana
- Lisa BallaminutLBLisa Ballaminut
- Giuseppe RicciGiuseppe Ricci
- Francesco De SetaFSFrancesco De Seta
- Gianpaolo MasoGMGianpaolo Maso
Open Access
- 12 April 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4298
Abstract
Respiratory infections are common in pregnancy with conflicting evidence supporting their association with neonatal congenital anomalies, especially during the first trimester. We profiled cytokine and chemokine systemic responses in 242 pregnant women and their newborns after SARS-CoV-2 infection, acquired in different trimesters. Also, we tested transplacental IgG passage and maternal vaginal–rectal microbiomes. IgG transplacental passage was evident, especially with infection acquired in the first trimester. G-CSF concentration—involved in immune cell recruitment—decreased in infected women compared to uninfected ones: a beneficial event for the reduction of inflammation but detrimental to ability to fight infections at birth. The later the infection was acquired, the higher the systemic concentration of IL-8, IP-10, and MCP-1, associated with COVID-19 disease severity. All infected women showed dysbiosis of vaginal and rectal microbiomes, compared to uninfected ones. Two newborns tested positive for SARS-CoV-2 within the first 48 h of life. Notably, their mothers had acute infection at delivery. Although respiratory infections in pregnancy are reported to affect babies’ health, with SARS-CoV-2 acquired early during gestation this risk seems low because of the maternal immune response. The observed vaginal and rectal dysbiosis could be relevant for neonatal microbiome establishment, although in our series immediate neonatal outcomes were reassuring.Keywords
Funding Information
- Italian Ministry of Health (Grant ID RC 27/22)
This publication has 55 references indexed in Scilit:
- Transplacental transfer of SARS-CoV-2 antibodies: a cohort studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2023
- Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 InfectionJAMA Pediatrics, 2021
- Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controlsAmerican Journal of Obstetrics and Gynecology, 2021
- Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal OutcomesJAMA, 2021
- Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJAMA Network Open, 2020
- Maternal death due to COVID-19American Journal of Obstetrics and Gynecology, 2020
- Coronavirus disease 2019 (COVID-19) pandemic and pregnancyAmerican Journal of Obstetrics and Gynecology, 2020
- Quantification, isolation and characterization of Bifidobacterium from the vaginal microbiomes of reproductive aged womenAnaerobe, 2017
- Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in PregnancyClinical Pharmacokinetics, 2017
- G-CSF and GM-CSF for treating or preventing neonatal infectionsCochrane Database of Systematic Reviews, 2003